We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

Africa’s biggest pharmaceutical manufacturer Aspen Pharmacare says it is well-positioned to help produce monkeypox vaccines, as it has spare capacity at its sterile facility in Gqeberha.

The World Health Organisation (WHO) declared monkeypox a public health emergency of international concern on Saturday, as the viral disease has rapidly spread in the past few months. By Thursday, more than 18,000 cases had been detected in 75 countries. The disease is usually mild, but health authorities are anxious to contain its spread to reduce the risk of it mutating into a more severe form, and several governments, including the US and UK, snapping up limited vaccine supplies...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.